Orot, Ricky C.
HRN: 27-35-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2025
07/03/2025
IV
600mg
Q6h
Infected Wound
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines